|
Hospitals and Clinics. "Even more importantly, we also
hope to learn if detecting those small abnormalities will
then actually allow us to treat the disease more effectively
and reduce the number of lung cancer deaths."
Forty
research centers across the nation will enroll 50,000 people
in the study, which is scheduled to last eight years. The
researchers are inviting men and women between the ages
of 55 and 74 who are a high risk for lung cancer because
of their smoking history to consider participating in the
trial.
The
National Cancer Institute (NCI) is sponsoring the National
Lung Screening Trial. McLennan will serve as The University
of Iowa's principal investigator. Brian Mullan, M.D., an
assistant professor in the Department of Radiology, will
serve as co-principal investigator.
"This is a very important study," said Mullan.
"An estimated 169,000 Americans will be diagnosed with
lung cancer this year alone, and 155,000 of them will die
of the disease."
For
more information about the National Lung Cancer Screening
Trial, contact the NCI by calling 1-800-4-CANCER or the
Cancer Information Service of Holden Comprehensive Cancer
Center at The University of Iowa at (319) 356-3000 or 1-800-237-1225,
or
by email at nlstiowa@uiowa.edu.
Information is also available online at http://www.cancer.gov/nlst
and http://www.uihealthcare.com/cancercenter.
|